GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » EKF Diagnostics Holdings PLC (OTCPK:EKDHF) » Definitions » Gross Margin %
中文

EKF Diagnostics Holdings (EKF Diagnostics Holdings) Gross Margin %

: 46.77% (As of Dec. 2023)
View and export this data going back to 2014. Start your Free Trial

Gross Margin % is calculated as gross profit divided by its revenue. EKF Diagnostics Holdings's Gross Profit for the six months ended in Dec. 2023 was $15.24 Mil. EKF Diagnostics Holdings's Revenue for the six months ended in Dec. 2023 was $32.58 Mil. Therefore, EKF Diagnostics Holdings's Gross Margin % for the quarter that ended in Dec. 2023 was 46.77%.

Warning Sign:

EKF Diagnostics Holdings PLC gross margin has been in long-term decline. The average rate of decline per year is -5.9%.


The historical rank and industry rank for EKF Diagnostics Holdings's Gross Margin % or its related term are showing as below:

EKDHF' s Gross Margin % Range Over the Past 10 Years
Min: 36.07   Med: 50.35   Max: 57.34
Current: 45.35


During the past 13 years, the highest Gross Margin % of EKF Diagnostics Holdings was 57.34%. The lowest was 36.07%. And the median was 50.35%.

EKDHF's Gross Margin % is ranked worse than
61.06% of 796 companies
in the Medical Devices & Instruments industry
Industry Median: 53.54 vs EKDHF: 45.35

EKF Diagnostics Holdings had a gross margin of 46.77% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for EKF Diagnostics Holdings was -5.90% per year.


EKF Diagnostics Holdings Gross Margin % Historical Data

The historical data trend for EKF Diagnostics Holdings's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EKF Diagnostics Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 52.82 57.34 48.10 36.07 45.35

EKF Diagnostics Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.12 43.35 26.72 43.99 46.77

Competitive Comparison

For the Medical Devices subindustry, EKF Diagnostics Holdings's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EKF Diagnostics Holdings Gross Margin % Distribution

For the Medical Devices & Instruments industry and Healthcare sector, EKF Diagnostics Holdings's Gross Margin % distribution charts can be found below:

* The bar in red indicates where EKF Diagnostics Holdings's Gross Margin % falls into.



EKF Diagnostics Holdings Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

EKF Diagnostics Holdings's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=30.2 / 66.596
=(Revenue - Cost of Goods Sold) / Revenue
=(66.596 - 36.395) / 66.596
=45.35 %

EKF Diagnostics Holdings's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=15.2 / 32.581
=(Revenue - Cost of Goods Sold) / Revenue
=(32.581 - 17.343) / 32.581
=46.77 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


EKF Diagnostics Holdings  (OTCPK:EKDHF) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

EKF Diagnostics Holdings had a gross margin of 46.77% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


EKF Diagnostics Holdings Gross Margin % Related Terms

Thank you for viewing the detailed overview of EKF Diagnostics Holdings's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


EKF Diagnostics Holdings (EKF Diagnostics Holdings) Business Description

Traded in Other Exchanges
Address
19 Stanwell Road, Penarth, Avon House, Cardiff, GBR, CF64 2EZ
EKF Diagnostics Holdings PLC is engaged in the field of medical diagnostics. The company's core business is point-of-care testing and manufacturing reagents for use in central laboratories. It caters to companies focused on areas such as diabetes, blood banking, and sports medicine. The company derives its income from its sales in the United States. Its other markets include Germany, Poland, and Russia.

EKF Diagnostics Holdings (EKF Diagnostics Holdings) Headlines

From GuruFocus